| |
 |
|
| Through
the LIBRA initiative Bayer aims to stop the development of resistance
to antibiotics. |
 |
The
report on infectious diseases published by the World Health Organization
(WHO) in 2000 shows that many pathogens are quickly becoming resistant
to antibiotics that could until recently be used to treat them. Experts
fear a return to the "pre-antibiotic era" with millions
of people dying from diseases the world believed were under control.
The battle against further resistance is thus one of the major medical
challenges of the 21st century. As one of the world's leading producers
of antibiotics, we have set up the LIBRA Project, a global initiative
to fight this problem. LIBRA is Latin for balance and symbolizes the
balanced nature of the antibiotic therapy. Together with leading health
care organizations and specialists, we aim to check the threat from
bacteria which rapidly develop a resistance to the antibiotics currently
available. We also want to raise the awareness of doctors, patients
and decision-makers to stop unconsidered and inappropriate use of
antibiotics. That is essential to ensure that they remain effective.
Further
information on LIBRA can be found on the website www.librainitiative.com.
|
|
World
Health
Organisation
LIBRA
|
